Back
Berkshire Hathaway Vs. Neurogene Industry Stock Comparison
Sell
45
BRK.A
Berkshire Hathaway
Last Price:
685,745.00
Seasonality Move:
5.52%
Sell
40
NGNE
Neurogene
Last Price:
41.53
Seasonality Move:
-0.92%
Sell
45
Berkshire Hathaway (BRK.A)
is a Sell
Is Berkshire Hathaway a Buy, Sell or Hold?
- The current Berkshire Hathaway [BRK.A] share price is $685,250.00. The Score for BRK.A is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- BRK.A is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $40.27. The Score for NGNE is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BRK.A Stock Price Chart
What is Berkshire Hathaway's stock price today?
-
The Berkshire Hathaway share price today is $685,250.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BRK.A is experiencing slight buying pressure.
NGNE Stock Price Chart
BRK.A Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5068.2 | Buy |
| Relative Strength Index (14 RSI): | 54.43 | Buy |
| Chaikin Money Flow: | 23 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (683022.42 - 683056.42) | Buy |
| Bollinger Bands (100): | (640347.76 - 640407.76) | Buy |
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1 | Buy |
| Relative Strength Index (14 RSI): | 57.44 | Buy |
| Chaikin Money Flow: | -29871 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.87 - 39.01) | Buy |
| Bollinger Bands (100): | (32.69 - 40.45) | Buy |
BRK.A Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 682099.2 | Buy |
| 20-day SMA: | 688427.18 | Sell |
| 50-day SMA: | 665091.07 | Buy |
| 200-day SMA: | 614118.34 | Buy |
| 8-day EMA: | 683230.57 | Buy |
| 20-day EMA: | 682310.12 | Buy |
| 50-day EMA: | 666654.38 | Buy |
| 200-day EMA: | 617840.45 | Buy |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.1 | Buy |
| 20-day SMA: | 36.84 | Buy |
| 50-day SMA: | 38.55 | Buy |
| 200-day SMA: | 33.4 | Buy |
| 8-day EMA: | 39.55 | Buy |
| 20-day EMA: | 37.91 | Buy |
| 50-day EMA: | 37.46 | Buy |
| 200-day EMA: | 33.1 | Buy |
Berkshire Hathaway Earnings Growth & BRK.A Earnings Dates
- Analysts estimate an earnings increase this quarter of $164.41 per share, an increase next quarter of $290.50 per share, an increase this year of $7,728.61 per share, and a decrease next year of $1,280.29 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.
Berkshire Hathaway Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurogene Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||